1733: Apex Biotechnology Corp. - Summary | Jitta

Apex Biotechnology Corp.

TWN:1733

Price
NT$28.55
Loss Chance
47.5%
5.21JITTA SCORE
157.42%Over Jitta Line
Jitta Ranking
648 / 1,077
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (49)
Recent Business Performance (73)
Financial Strength (85)
Return to Shareholders (28)
Competitive Advantage (47)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
CapExVery Low
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.21
157.42%
3.79
645.83%
Health Care Equipment
5.25
64.42%
4.12
76.04%
2.02
> 1,000%
COMPANY DESCRIPTION
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is based in Hsinchu City, Taiwan.